Stock listing
Immuneering Corporation
Selected listing: IMRX · NASDAQ · USD · US
Immuneering Corporation (NASDAQ:IMRX), Health Technology. Latest release Oct 2, 2026: Immuneering to Present at the 41st Annual Meeting of the Society…
- Ticker
- NASDAQ:IMRX
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
About Immuneering Corporation
Immuneering Corporation, trading under the ticker IMRX, is a public company based in the United States. Immuneering focuses on developing innovative therapies for cancer and other serious diseases through its proprietary drug discovery platform.
Latest news from Immuneering Corporation
Immuneering to Present at the 41st Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
October 2, 2026
Immuneering to Present at the 41st Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
October 1, 2026
Immuneering Presents Data at 2026 AACR Conference on Pancreatic Cancer Supporting Atebimetinib’s Mechanisms Designed to Extend Survival in Pancreatic Cancer
September 28, 2026
Immuneering to Present at the ESMO Congress 2026
September 24, 2026
Immuneering to Present at the AACR Conference on Pancreatic Cancer, Highlighting Atebimetinib’s Dual Mechanism for Extended Survival
September 10, 2026
Events
Research Immuneering Corporation
Immuneering Corporation company profile
View the public company page for Immuneering Corporation on 6ix.
Immuneering Corporation news
Read company news and market updates connected to Immuneering Corporation.
Immuneering Corporation investor events
Find investor webinars, events, and replay context for Immuneering Corporation.